Hepatitis B vaccination in uremic patients: comparison between recombinant and plasma-derived vaccine.

R. Bergia,M. Pellerey,I. Berto,E. Caramello,P. Dionisio,M. Valenti,C. Converso,G. Garbaccio,P. Bajardi
Nephron
Abstract:The immune response to recombinant and plasma-derived vaccines was evaluated in 53 and 43 uremic patients, respectively. The total rate of seroconversion was around 80% with both vaccines, although a significantly higher response was obtained with the protocol using recombinant vaccine.
What problem does this paper attempt to address?